Global Label-free Detection (LFD) Market 2022-2026

Description

List of Tables

Technavio has been monitoring the label-free detection (LFD) market and it is poised to grow by $362.6 mn during 2022-2026, accelerating at a CAGR of 7.79% during the forecast period. Our report on the label-free detection (LFD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising in drug discovery programs, an increase in contract research organizations (CROs) in developing countries, and the advantages of LFD.

The label-free detection (LFD) market analysis includes end-user, product segment, and geographic landscape.

Technavio's label-free detection (LFD) market is segmented as below:

By End-user

Pharmaceutical and biotechnology companies
Contract research organizations (CROs)
Academic and research institutes

By Product

Biochemical assays
Cell-based assays

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the new product launches as one of the prime reasons driving the label-free detection (LFD) market growth during the next few years. Also, the demand for personalized medicine and the growing prevalence of LFD for testing Covid-19 will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the label-free detection (LFD) market covers the following areas:

Label-free detection (LFD) market sizing
Label-free detection (LFD) market forecast
Label-free detection (LFD) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading label-free detection (LFD) market vendors that include Affinite Instruments, Agilent Technologies Inc., AMETEK Inc., Attana AB, Bio Rad Laboratories Inc., BioNavis Ltd., BiOptix Analytical LLC, Bruker Corp., Corning Inc., Danaher Corp., HORIBA Ltd., OLS OMNI Life Science GmbH and Co. KG, PerkinElmer Inc., Sartorius AG, Spectris Plc, SYMCEL, Thermo Fisher Scientific Inc., Waters Corp., Wyatt Technology Corp., and General Electric Co. Also, the label-free detection (LFD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74641

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
Exhibit 25: Chart on End-user - Market share 2021-2026 (%)
Exhibit 26: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 27: Chart on Comparison by End-user
Exhibit 28: Data Table on Comparison by End-user
5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
Exhibit 29: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibit 31: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibit 32: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
5.4 Contract research organizations (CROs) - Market size and forecast 2021-2026
Exhibit 33: Chart on Contract research organizations (CROs) - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Data Table on Contract research organizations (CROs) - Market size and forecast 2021-2026 ($ million)
Exhibit 35: Chart on Contract research organizations (CROs) - Year-over-year growth 2021-2026 (%)
Exhibit 36: Data Table on Contract research organizations (CROs) - Year-over-year growth 2021-2026 (%)
5.5 Academic and research institutes - Market size and forecast 2021-2026
Exhibit 37: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 39: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibit 40: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
Exhibit 41: Market opportunity by End-user ($ million)

6 Market Segmentation by Product

6.1 Market segments
Exhibit 42: Chart on Product - Market share 2021-2026 (%)
Exhibit 43: Data Table on Product - Market share 2021-2026 (%)
6.2 Comparison by Product
Exhibit 44: Chart on Comparison by Product
Exhibit 45: Data Table on Comparison by Product
6.3 Biochemical assays - Market size and forecast 2021-2026
Exhibit 46: Chart on Biochemical assays - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Biochemical assays - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Biochemical assays - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Biochemical assays - Year-over-year growth 2021-2026 (%)
6.4 Cell-based assays - Market size and forecast 2021-2026
Exhibit 50: Chart on Cell-based assays - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Cell-based assays - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Cell-based assays - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Cell-based assays - Year-over-year growth 2021-2026 (%)
6.5 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ million)

7 Customer Landscape

7.1 Customer landscape overview
Exhibit 55: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
Exhibit 56: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 57: Data Table on Market share By Geographical Landscape 2021-2026 (%)
8.2 Geographic comparison
Exhibit 58: Chart on Geographic comparison
Exhibit 59: Data Table on Geographic comparison
8.3 North America - Market size and forecast 2021-2026
Exhibit 60: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 61: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 62: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 63: Data Table on North America - Year-over-year growth 2021-2026 (%)
8.4 Europe - Market size and forecast 2021-2026
Exhibit 64: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 65: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 66: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 67: Data Table on Europe - Year-over-year growth 2021-2026 (%)
8.5 Asia - Market size and forecast 2021-2026
Exhibit 68: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 69: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 70: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 71: Data Table on Asia - Year-over-year growth 2021-2026 (%)
8.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 72: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 73: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 74: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 75: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
8.7 US - Market size and forecast 2021-2026
Exhibit 76: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 77: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 78: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 79: Data Table on US - Year-over-year growth 2021-2026 (%)
8.8 Germany - Market size and forecast 2021-2026
Exhibit 80: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 81: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 82: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 83: Data Table on Germany - Year-over-year growth 2021-2026 (%)
8.9 China - Market size and forecast 2021-2026
Exhibit 84: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 85: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 86: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 87: Data Table on China - Year-over-year growth 2021-2026 (%)
8.10 UK - Market size and forecast 2021-2026
Exhibit 88: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 89: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 90: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 91: Data Table on UK - Year-over-year growth 2021-2026 (%)
8.11 France - Market size and forecast 2021-2026
Exhibit 92: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 93: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 94: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 95: Data Table on France - Year-over-year growth 2021-2026 (%)
8.12 Market opportunity By Geographical Landscape
Exhibit 96: Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Trends

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 97: Impact of drivers and challenges in 2021 and 2026
9.4 Market trends

10 Vendor Landscape

10.1 Overview
10.2 Vendor landscape
Exhibit 98: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 99: Overview on factors of disruption
10.4 Industry risks
Exhibit 100: Impact of key risks on business

11 Vendor Analysis

11.1 Vendors covered
Exhibit 101: Vendors covered
11.2 Market positioning of vendors
Exhibit 102: Matrix on vendor position and classification
11.3 Agilent Technologies Inc.
Exhibit 103: Agilent Technologies Inc. - Overview
Exhibit 104: Agilent Technologies Inc. - Business segments
Exhibit 105: Agilent Technologies Inc. - Key news
Exhibit 106: Agilent Technologies Inc. - Key offerings
Exhibit 107: Agilent Technologies Inc. - Segment focus
11.4 Bio Rad Laboratories Inc.
Exhibit 108: Bio Rad Laboratories Inc. - Overview
Exhibit 109: Bio Rad Laboratories Inc. - Business segments
Exhibit 110: Bio Rad Laboratories Inc. - Key news
Exhibit 111: Bio Rad Laboratories Inc. - Key offerings
Exhibit 112: Bio Rad Laboratories Inc. - Segment focus
11.5 Corning Inc.
Exhibit 113: Corning Inc. - Overview
Exhibit 114: Corning Inc. - Business segments
Exhibit 115: Corning Inc. - Key offerings
Exhibit 116: Corning Inc. - Segment focus
11.6 Danaher Corp.
Exhibit 117: Danaher Corp. - Overview
Exhibit 118: Danaher Corp. - Business segments
Exhibit 119: Danaher Corp. - Key news
Exhibit 120: Danaher Corp. - Key offerings
Exhibit 121: Danaher Corp. - Segment focus
11.7 General Electric Co.
Exhibit 122: General Electric Co. - Overview
Exhibit 123: General Electric Co. - Business segments
Exhibit 124: General Electric Co. - Key news
Exhibit 125: General Electric Co. - Key offerings
Exhibit 126: General Electric Co. - Segment focus
11.8 HORIBA Ltd.
Exhibit 127: HORIBA Ltd. - Overview
Exhibit 128: HORIBA Ltd. - Business segments
Exhibit 129: HORIBA Ltd. - Key news
Exhibit 130: HORIBA Ltd. - Key offerings
Exhibit 131: HORIBA Ltd. - Segment focus
11.9 PerkinElmer Inc.
Exhibit 132: PerkinElmer Inc. - Overview
Exhibit 133: PerkinElmer Inc. - Business segments
Exhibit 134: PerkinElmer Inc. - Key news
Exhibit 135: PerkinElmer Inc. - Key offerings
Exhibit 136: PerkinElmer Inc. - Segment focus
11.10 Sartorius AG
Exhibit 137: Sartorius AG - Overview
Exhibit 138: Sartorius AG - Business segments
Exhibit 139: Sartorius AG - Key news
Exhibit 140: Sartorius AG - Key offerings
Exhibit 141: Sartorius AG - Segment focus
11.11 Spectris Plc
Exhibit 142: Spectris Plc - Overview
Exhibit 143: Spectris Plc - Business segments
Exhibit 144: Spectris Plc - Key news
Exhibit 145: Spectris Plc - Key offerings
Exhibit 146: Spectris Plc - Segment focus
11.12 Thermo Fisher Scientific Inc.
Exhibit 147: Thermo Fisher Scientific Inc. - Overview
Exhibit 148: Thermo Fisher Scientific Inc. - Business segments
Exhibit 149: Thermo Fisher Scientific Inc. - Key news
Exhibit 150: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 151: Thermo Fisher Scientific Inc. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 152: Inclusions checklist
Exhibit 153: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 154: Currency conversion rates for US$
12.4 Research methodology
Exhibit 155: Research methodology
Exhibit 156: Validation techniques employed for market sizing
Exhibit 157: Information sources
12.5 List of abbreviations
Exhibit 158: List of abbreviations
- growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
- product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.